Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of lorazepam injection for pre-anesthetic medication
CTR20243931Phase 3Completed
- Sponsor
- Jiangsu Nhwa Pharmaceutical
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lorazepam in preoperative anxiety, sponsored by Jiangsu Nhwa Pharmaceutical. Started Nov 2024; status: completed.
02
Drugs
lorazepam
03
Conditions
preoperative anxiety
Beyond the preview
Go deeper on CTR20243931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243931.